About Sanofi (EPA:SAN)
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company's segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme.
Industry, Sector and Symbol:
- Industry: Drug Manufacturers - Major
- Sub-Industry: N/A
- Sector: Healthcare
- Symbol: EPA:SAN
- CUSIP: N/A
- Web: en.sanofi.com
- Trailing EPS: €3.61
- Net Margins: 15.85%
- Outstanding Shares: 1,260,000,000
Frequently Asked Questions for Sanofi (EPA:SAN)
What is Sanofi's stock symbol?
Sanofi trades on the EPA under the ticker symbol "SAN."
Where is Sanofi's stock going? Where will Sanofi's stock price be in 2017?
15 brokerages have issued 1-year price targets for Sanofi's shares. Their predictions range from €75.00 to €100.00. On average, they expect Sanofi's share price to reach €88.20 in the next year. View Analyst Ratings for Sanofi.
Who are some of Sanofi's key competitors?
Some companies that are related to Sanofi include Bayer AG (BAYN), CSL Limited (CSL), Essilor International Société Anonyme (EI), Ramsay Health Care Limited (RHC), Merck KGaA (MRK), AEGON (AGN), Cochlear Limited (COH), Sonic Healthcare Limited (SHL), Valeant Pharmaceuticals International (VRX), Shire-Nps Pharmaceuticals (NPSP), Ansell Limited (ANN), Enerplus Corp (ERF), Primary Health Care Limited (PRY), ProMetic Life Sciences (PLI), Canfor Pulp Products (CFX), Gentium Srl (GENTY), Novadaq Technologies (NDQ) and Extendicare (EXE).
Who are Sanofi's key executives?
Sanofi's management team includes the folowing people:
- Serge Weinberg, Independent Chairman of the Board (Age 66)
- Olivier Brandicourt, Chairman of the Executive Committee, Chief Executive Officer, Director (Age 61)
- Jerome Contamine, Executive Vice President, Chief Financial Officer, Member of the Executive Committee (Age 59)
- Karen Marie Linehan, Executive Vice President, Legal Affairs and General Counsel; Member of the Executive Committee (Age 58)
- Olivier Charmeil, Executive Vice President and General Manager, General Medicines & Emerging Markets; Member of the Executive Committee (Age 54)
- Roberto Pucci, Executive Vice President, Human Resources; Member of the Executive Committee (Age 53)
- Peter Guenter, Executive Vice President, Diabetes & Cardiovascular; Member of the Executive Committee (Age 55)
- David Loew, Executive Vice President, Sanofi Pasteur; Member of the Executive Committee
- Philippe Luscan, Executive Vice President, Global Industrial Affairs; Member of the Executive Committee (Age 55)
- Alan J. Main Ph.D., Executive Vice President, Consumer Healthcare; Member of the Executive Committee (Age 63)
What is Sanofi's stock price today?
One share of Sanofi stock can currently be purchased for approximately €75.54.
How big of a company is Sanofi?
Sanofi has a market capitalization of $95.42 billion.
How can I contact Sanofi?
MarketBeat Community Rating for Sanofi (EPA SAN)MarketBeat's community ratings are surveys of what our community members think about Sanofi and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Sanofi's mailing address is 54 rue la Boetie, PARIS, 75008, France. The company can be reached via phone at +33-1-53774000.
Analysts' Consensus Ratings for Sanofi (EPA:SAN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 9 Hold Ratings, 5 Buy Ratings, 0 Strong Buy Ratings|
|Consensus Rating:||Hold (Score: 2.27)|
|Consensus Price Target: ||€88.20|Consensus Price Target History for Sanofi (EPA:SAN)
Analysts' Ratings History for Sanofi (EPA:SAN)
(Data available from 11/17/2015 forward)
|11/3/2017||S&P Global||Set Price Target||Neutral||€83.00|
|11/3/2017||The Goldman Sachs Group, Inc.||Set Price Target||Neutral||€82.00|
|11/2/2017||Berenberg Bank||Set Price Target||Neutral||€97.00|
|11/2/2017||J P Morgan Chase & Co||Reiterated Rating||Neutral|
|10/26/2017||Morgan Stanley||Set Price Target||Buy||€92.00|
|10/18/2017||Deutsche Bank AG||Set Price Target||Buy||€96.00|
|10/16/2017||Jefferies Group LLC||Set Price Target||Neutral||€90.00|
|10/6/2017||Citigroup Inc.||Set Price Target||Neutral||€88.00|
|9/12/2017||BNP Paribas||Set Price Target||Neutral||€85.00|
|9/7/2017||Kepler Capital Markets||Set Price Target||Buy||€90.00|
|7/31/2017||Sanford C. Bernstein||Set Price Target||Neutral||€90.00|
|7/4/2017||Credit Suisse Group||Set Price Target||Buy||€95.00|
|5/8/2017||Barclays PLC||Set Price Target||Sell||€75.00|
|3/23/2017||Societe Generale||Set Price Target||Buy||€100.00|
|12/6/2016||S&P Global Inc.||Set Price Target||Neutral||€80.00|
|6/30/2016||Independent Research GmbH||Set Price Target||Neutral||€77.00|
|6/9/2016||Baader Bank||Set Price Target||Neutral||€78.00|
|2/9/2016||S&P Equity Research||Set Price Target||Buy||€85.00|
Earnings History for Sanofi (EPA:SAN)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Sanofi (EPA:SAN)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Sanofi (EPA:SAN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Sanofi (EPA SAN)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Sanofi (EPA:SAN)
Latest Headlines for Sanofi (EPA SAN)
Financials are not available for this stock.